AINCP’s Post

Check out the partner introduction of our research group ReGEDiM VUB in the ESCORT Project, funded by the European Union’s Horizon research and innovation programme. In the project we work together with different partners across Europe to drive forward AI enabled healthcare services during cross-border medical emergencies and regular patient services. #AI #VUB #VUBReGEDiM #Healthcare #Innovation #European #UZBrussel #EmergencyMedicine #Research

Integrate Ukrainian researchers into the global research community. The Regional Cooperation for Health, Science, and Technology (RECOOP HST) Consortium, led by Cedars-Sinai Medical Center, was formed in 2006 and transformed into an Association in 2012 that includes 19 universities and academic organizations from eight countries in Central and Eastern Europe (Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, and Ukraine). USA is working as a research organization. According to its mission statement: "The RECOOP HST Association explores and enhances LOCAL scientific outputs of the partner organizations, creates a critical mass of scientifically sound innovative research at the REGIONAL level and exploits the research outcomes at the GLOBAL level to improve the prevention and treatment of major public health problems."™ RECOOP Scientists made hemostatic kits developed in the frame Cedars - RECOOP Grant #032 "Improved Hemostatic Device with Chitosan Powder for Combat Injury Dressing" are on the way to the frontline in Ukraine.

Highly honoured and extremely thrilled to host and preside over "The First International Symposium for Digital Twins in Healthcare" on 16-17 May 2024 - Ayia Napa, Cyprus Imagine a revolution in personalized healthcare and disease prevention systems in Europe, based on human avatars of healthy individuals and patients for the prevention, interception and cure of disease. Nothing less is the aim of the First International Symposium on Digital Twins in Healthcare, taking place in Ayia Napa, Cyprus on May 16-17, 2024 (DigitalTwin4Health2024). This unprecedented event aspires to become the stage for multidisciplinary initiatives in Europe aiming for a paradigm shift in healthcare and for a future sustainable healthcare system. Digital Twins are making possible a revolution in human model development by leveraging data from multi-omics analyses, medical and imaging data, environmental and life style big data that are continuously updated by a multitude of biosensors at an unprecedented scale. With these complex data sets, first of their kind(s) Human Digital- Physical Twins can be personalized and used to prevent and cure each one’s own disease(s). The Symposium is calling for contributions across the following scientific, translational and policy-making pillars: • Emerging Technologies for Digital Twins. • Designing and building data and model repositories. • Development, testing and implementation of IT platform architectures combining computational advances, cybersecurity, cloud services and edge infrastructure. • Clinical Translation – Industrial Uptake, including standardization and interoperability. • Ethical Considerations and Societal Adoption. • Transformational Vision – Policy Creation and Implementation Towards Proactive Healthcare. As the Symposium’s central activity, a specially designated forum with high-level European Commission and European Parliament representation will provide the floor for productive dialogue and policy making. Important Dates: Abstract Submission Deadline: February 23rd, 2024 Notification of Acceptance: March 8th, 2024 Symposium Dates: May 16-17, 2024 #DigitalTwinsinHealthcare #ArtificialIntelligenceInHealth #EPOSIASIS #EuropeanInnovationCouncil #HORIZONEUROPE #DigiPredict #EDITH #Optimics #NeuroTwins

Thrilled to be part of this significant international project, collaborating with outstanding partners to explore the REAL potential of synthetic data in healthcare. This includes privacy-preserving data sharing, bias mitigation, data augmentation, digital twins, and more. At the Biomedical Data Science Center of CHUV | Lausanne university hospital and University of Lausanne - UNIL, our team will focus on developing cutting-edge algorithms to rigorously assess the privacy and utility of synthetic data, key elements in building TRUST in this powerful emerging technology. Stay tuned for updates and follow IHI-SYNTHIA for more exciting news! #ai4healthcare #syntheticdata #privacy #precisionmedicine

[#Webinar] D-8 until our next QuanTIM Webinar! ⤵ 💬 Combining Randomized Control Trial and Observational Data 🗣 julie josse (Inria, Inserm, Université de Montpellier) 💻 https://lnkd.in/dz2me6ah ------- Interested in a QuanTIM Webinar's panelist spot and a funding for a scientific conference or a research stay in one of the SESSTIM’s teams? Check-out PhD Student Award! 🎓🏅 ➡ https://lnkd.in/dvJatmMx ------- ⬇⬇ Abstract ⬇⬇ Randomized Controlled Trials (RCTs) are pivotal in evidence-based medicine, estimating average treatment effects by averting confounding factors. However, concerns about RCT limitations—strict eligibility criteria, real-world impracticality, and small sample sizes—threaten their generalization to diverses populations. We will developp transportability methods by integrating non-randomized observational data to extend trial findings to other populations, potentially facing distributional shifts. #PublicHealth #CausalInference #ClinicalTrials #Transportability #TreatmentEffect #DoubleRobustness Cc. Aix-Marseille Université, IRD, Santé publique France, ISSPAM, Société Française de Santé Publique (SFSP), Collège de Liaison des Internes de Santé Publique (CLISP), EUPHA - European Public Health Association, EuroHealthNet, European Public Health Alliance (EPHA), Young WFPHA

Our #CTSCCLEHealth Director of Evaluation, Dr. Clara M. Pelfrey, and Dr. Deborah DiazGranados, Director of Evaluation at VCU C. Kenneth and Dianne Wright Center for Clinical and Translational Research, along with their colleagues are co-leading a national CTSA Working Group focused on 'Learning about the science of translation: Identifying best practices to accelerate the translational process through case studies'. The workgroup will conduct a comparative analysis of many kinds of successful translational science case studies.   The purpose of this collaboration is to generate new knowledge about the nature of the translational process by investigating and comparing successful translational science cases that have led to positive impacts on human health. Currently the collaboration has attracted 25 unique institutions/CTSA hubs. 🎉 👏 🎈 CTSA CCOS Center #CTSAProgam #TranslationalScience

🚀 𝗠𝗮𝗷𝗼𝗿 𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗶𝗻 𝗔𝗜-𝗕𝗮𝘀𝗲𝗱 𝗧𝗕 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻! Rayscape has been spotlighted in a groundbreaking study published in The Lancet 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵. Here's what you need to know: 🌟 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: - Evaluated 12 CAD products with 774 participants in South Africa. - XVision (now known as Rayscape) achieved high sensitivity, placing us in the 1st tier of detection power. - Products reduced the need for confirmatory testing by over 40%. 📊 𝗜𝗺𝗽𝗮𝗰𝘁𝗳𝘂𝗹 𝗥𝗲𝘀𝘂𝗹𝘁𝘀: - Supported integrating AI-based CAD products into TB screening to enhance diagnostic efficiency. - Highlighted the need for appropriate thresholds for different populations to ensure high accuracy. - Called for a global strategy to validate new CAD products and versions. 🔍 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗠𝗼𝗿𝗲 & 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝗪𝗶𝘁𝗵 𝗨𝘀: 📄 For the full study, read here: https://lnkd.in/dbZ7TJNQ 🌐 Discover our innovations: https://rayscape.ai/ South African Medical Research Council, HSRC (Human Sciences Research Council), National Institute for Communicable Diseases (NICD), Department of Health South Africa, World Health Organization South Africa, Universität Heidelberg #Rayscape #AI #Healthcare #Tuberculosis #Innovation #DigitalHealth #TopTier #DiagnosticEfficiency #EndTB

We are thrilled to announce the release of our latest video, which dives into the details of the DECISION project - a European research consortium, aiming to enhance our understanding of decompensated cirrhosis and acute-on-chronic liver failure at a systems level. 🎥 Join in, as project partners discuss their roles within the project and emphasise the importance of collaboration in advancing scientific research. Learn more about the upcoming clinical trial and the role and representation of patients within DECISION. Get to know our speakers: Pierre-Emmanuel Rautou, scientific coordinator of DECISION, INSERM, Greater Paris University Hospitals - AP-HP, European Foundation for the Study of Chronic Liver Failure (EF CLIF) Sara Palomino Echeverría, researcher patient stratification team, Navarrabiomed, biomedical research centre CARACENI Paolo, Leader of the #COMBATtrial, ALMA MATER STUDIORUM UNIVERSITÀ DI BOLOGNA Pr. Isabelle Durand-Zaleski, Leader Health Economics, Greater Paris University Hospitals - AP-HP Veronika Všetíčková, Patient Representative, European Liver Patients' Association - ELPA   🔍 Watch the full video here or on YouTube: https://lnkd.in/dxzURBMx 📲 Follow us here on LinkedIn to stay informed about the project progress and the latest developments in scientific research on decompensated cirrhosis.   #Cirrhosis #ACLF #Hepatology #DecompensatedCirrhosis #MedicalResearch #Horizon2020

At our recent Annual Scientific Meeting, our media team asked delegates one simple question: ”Why do you do what you do?” Their answers fascinated and inspired us… and perhaps made us well up a little 👀 Now it’s your turn; we’d love to hear from you in the comments section. #SCIProfessionals #SpinalCordInjuryCare #NeuroRehabilitation #SCISpecialists #SCIResearch #SCIMedicine #SCIInEurope #EuropeanSCISpecialists #EuropeSCIResearch #NeuroCareEurope #SpinalCareEurope #ISCOS2024 #SCISymposium #MedicalConferences2024 #SCINetworking #MedicalMotivation